应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ARAV Aravive, Inc.
休市中 02-22 16:00:00 EST
0.0401
+0.0000
0.00%
最高
0.0401
最低
0.0401
成交量
0.00
今开
0.0401
昨收
0.0401
日振幅
0.00%
总市值
294.99万
流通市值
180.76万
总股本
7,356万
成交额
0.00
换手率
0.00%
流通股本
4,508万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Aravive Inc盘中异动 早盘股价大跌5.04%报0.115美元
自选股智能写手 · 01-16
Aravive Inc盘中异动 早盘股价大跌5.04%报0.115美元
Aravive Inc盘中异动 早盘急速跳水5.13%
自选股智能写手 · 2023-12-18
Aravive Inc盘中异动 早盘急速跳水5.13%
加载更多
公司概况
公司名称:
Aravive, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aravive, Inc.(纳斯达克股票代码:ARAV于2018年10月16日生效)是一家临床阶段的生物技术公司,该公司致力于针对癌症生存途径的创新疗法的开发。 Aravive的主要候选物AVB-S6-500是一种新型高亲和力可溶性Fc融合蛋白,旨在通过拦截GAS6与其受体AXL的结合来阻断GAS6-AXL信号通路的激活。 AXL受体信号通过阻碍癌细胞存活,对治疗的抗性和免疫抑制在多种类型的恶性肿瘤中起重要作用。 Aravive预计将在2018年底之前启动AVB-S6-500 1b / 2期临床试验的1b期部分与铂类抗性卵巢癌患者的标准治疗相结合,并打算将其发展为新的抗肿瘤业务。
发行价格:
--
{"stockData":{"symbol":"ARAV","market":"US","secType":"STK","nameCN":"Aravive, Inc.","latestPrice":0.0401,"timestamp":1708635600000,"preClose":0.0401,"halted":0,"volume":0,"delay":0,"floatShares":45076660,"shares":73562648,"eps":-0.902157,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"02-22 16:00:00 EST","open":0.0401,"high":0.0401,"low":0.0401,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.902157,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1395374400000,"adjPreClose":0.0401,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/ARAV/","defaultTab":"news","newsList":[{"id":"2403186008","title":"Aravive Inc盘中异动 早盘股价大跌5.04%报0.115美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2403186008","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2403186008?lang=zh_cn&edition=full","pubTime":"2024-01-16 22:35","pubTimestamp":1705415712,"startTime":"0","endTime":"0","summary":"北京时间2024年01月16日22时35分,Aravive Inc股票出现异动,股价快速下跌5.04%。截至发稿,该股报0.115美元/股,成交量17.769万股,换手率0.24%,振幅3.97%。Aravive Inc股票所在的生物技术行业中,整体跌幅为0.44%。Aravive Inc公司简介:Aravive Inc 是一家临床阶段的生物制药公司。Batiraxcept 目前正在多项临床试验中进行评估。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401162235137a3ba261&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401162235137a3ba261&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392999733","title":"Aravive Inc盘中异动 早盘急速跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2392999733","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392999733?lang=zh_cn&edition=full","pubTime":"2023-12-18 22:46","pubTimestamp":1702910763,"startTime":"0","endTime":"0","summary":"北京时间2023年12月18日22时46分,Aravive Inc股票出现异动,股价大幅下跌5.13%。截至发稿,该股报0.131美元/股,成交量17.0669万股,换手率0.23%,振幅2.89%。Aravive Inc股票所在的生物技术行业中,整体涨幅为0.06%。Aravive Inc公司简介:Aravive Inc 是一家临床阶段的生物制药公司。Batiraxcept 目前正在多项临床试验中进行评估。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231218224607861c576b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231218224607861c576b&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aravive.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":-0.7136},{"period":"1year","weight":-0.9748},{"period":"ytd","weight":-0.6758}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aravive, Inc.(纳斯达克股票代码:ARAV于2018年10月16日生效)是一家临床阶段的生物技术公司,该公司致力于针对癌症生存途径的创新疗法的开发。 Aravive的主要候选物AVB-S6-500是一种新型高亲和力可溶性Fc融合蛋白,旨在通过拦截GAS6与其受体AXL的结合来阻断GAS6-AXL信号通路的激活。 AXL受体信号通过阻碍癌细胞存活,对治疗的抗性和免疫抑制在多种类型的恶性肿瘤中起重要作用。 Aravive预计将在2018年底之前启动AVB-S6-500 1b / 2期临床试验的1b期部分与铂类抗性卵巢癌患者的标准治疗相结合,并打算将其发展为新的抗肿瘤业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.106226},{"month":2,"riseRate":0.666667,"avgChangeRate":0.088742},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.004583},{"month":4,"riseRate":0.25,"avgChangeRate":0.044546},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.026991},{"month":6,"riseRate":0.5,"avgChangeRate":0.012858},{"month":7,"riseRate":0.5,"avgChangeRate":-0.085732},{"month":8,"riseRate":0.5,"avgChangeRate":-0.11967},{"month":9,"riseRate":0.2,"avgChangeRate":-0.134525},{"month":10,"riseRate":0.2,"avgChangeRate":-0.030734},{"month":11,"riseRate":0.7,"avgChangeRate":0.104001},{"month":12,"riseRate":0.4,"avgChangeRate":0.009216}],"exchange":"NASDAQ","name":"Aravive, Inc.","nameEN":"Aravive, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aravive, Inc.(ARAV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aravive, Inc.(ARAV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aravive, Inc.,ARAV,Aravive, Inc.股票,Aravive, Inc.股票老虎,Aravive, Inc.股票老虎国际,Aravive, Inc.行情,Aravive, Inc.股票行情,Aravive, Inc.股价,Aravive, Inc.股市,Aravive, Inc.股票价格,Aravive, Inc.股票交易,Aravive, Inc.股票购买,Aravive, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aravive, Inc.(ARAV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aravive, Inc.(ARAV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}